Biomarin Pharmaceutical Inc (BMRN)

Market is closed

Insider Trading: Sales

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Grey Director	$69.66	30,000	$2,089,680.00	23,050	2013-12-11	Filing
Lewis Director	$69.91	22,500	$1,572,981.75	19,300	2013-12-09	Filing
Lawlis Director	$69.76	2,900	$202,300.81	11,400	2013-12-09	Filing
Ajer Officer	$69.55	13,026	$906,010.40	14,880	2013-12-09	Filing
Bienaime Officer, Director	$69.70	5,000	$348,484.50	50,740	2013-12-05	Filing
Spiegelman Officer	$70.14	9,000	$631,272.60	37,950	2013-12-02	Filing
Bienaime Officer, Director	$62.36	5,000	$311,779.00	45,740	2013-11-05	Filing
Ajer Officer	$63.16	99	$6,252.84	14,880	2013-11-01	Filing
Bienaime Officer, Director	$62.72	10,000	$627,155.00	45,740	2013-10-31	Filing
Bienaime Officer, Director	$67.73	2,000	$135,450.00	45,740	2013-10-16	Filing
Bienaime Officer, Director	$66.76	3,000	$200,291.10	45,740	2013-10-10	Filing
Fuchs Officer	$80.19	10,000	$801,900.00	43,266	2013-09-19	Filing
Bienaime Officer, Director	$73.08	2,000	$146,163.00	48,740	2013-09-16	Filing
Baffi Officer	$73.00	20,000	$1,460,000.00	62,262	2013-09-09	Filing
Fuchs Officer	$70.00	10,000	$700,000.00	43,266	2013-09-05	Filing
Spiegelman Officer	$69.00	9,000	$621,000.00	37,950	2013-09-04	Filing
Bienaime Officer, Director	$64.36	1,000	$64,364.00	48,740	2013-08-15	Filing
Spiegelman Officer	$59.56	2,033	$121,083.04	37,950	2013-07-01	Filing
Spiegelman Officer	$60.00	2,033	$121,980.00	39,983	2013-07-01	Filing
Fuchs Officer	$60.00	10,000	$600,000.00	43,266	2013-07-01	Filing